Welcome to LookChem.com Sign In|Join Free
  • or
[3R,4R]-1-Benzyloxycarbonyl-3-ethenyl-4-[3-(6-methoxyquinolin-4-yl)but-3-en]piperidine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

233745-90-9

Post Buying Request

233745-90-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

233745-90-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 233745-90-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,3,7,4 and 5 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 233745-90:
(8*2)+(7*3)+(6*3)+(5*7)+(4*4)+(3*5)+(2*9)+(1*0)=139
139 % 10 = 9
So 233745-90-9 is a valid CAS Registry Number.

233745-90-9Downstream Products

233745-90-9Relevant academic research and scientific papers

COMPLEX AND STRUCTURALLY DIVERSE COMPOUNDS

-

Paragraph 0270; 0271, (2015/12/20)

The invention provides a novel, general, and facile strategy for the creation of small molecules with high structural and stereochemical complexity. Aspects of the methods include ring system distortion reactions that are systematically applied to rapidly convert readily available natural products to structurally complex compounds with diverse molecular architectures. Through evaluation of chemical properties including fraction of sp3 carbons, ClogP, and the number of stereogenic centers, these compounds are shown to be significantly more complex and diverse than those in standard screening collections. This approach is demonstrated with natural products (gibberellic acid, adrenosterone, and quinine) from three different structural classes, and methods are described for the application of this strategy to any suitable natural product.

QUINOLINE DERIVATIVES AS ANTIBACTERIALS

-

, (2008/06/13)

A method of treatment of bacterial infections in mammals, particularly in man, which method comprises the administration to a mammal in need of such treatment of an effective amount of a quinoline of formula (I) or a pharmaceutically acceptable derivative thereof wherein: n is 0, 1 or 2; A is NR, O, S(O)x or CRR and B is NR, O, S(O)x or CRR where x is 0, 1 or 2 novel quinolines for use in the method.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 233745-90-9